Interference, Opposition, Reexamination and Reissue. Merck and Metabasis, shall inform the other of any request for, or filing or declaration of, any interference, opposition, or reexamination relating to the Prior Patents or Collaboration Patents within thirty (30) days of learning of such event. [***] be the lead party in any such interference, opposition, or reexamination relating to the Prior Patents or Collaboration Patents, subject to the provisions of this Section 7.2.4(c). [***] shall have the right to review and consult with [***] regarding any submission to be made in connection with such proceeding. Notwithstanding the foregoing or any other provision of this Agreement to the contrary:
Appears in 3 contracts
Samples: License and Research Collaboration Agreement (Metabasis Therapeutics Inc), License and Research Collaboration Agreement (Metabasis Therapeutics Inc), License and Research Collaboration Agreement (Metabasis Therapeutics Inc)
Interference, Opposition, Reexamination and Reissue. Merck and Metabasis, Metabasis shall inform the other of any request for, or filing or declaration of, any interference, opposition, or reexamination relating to the Prior Joint Patents or Collaboration Product Patents within thirty (30) days of learning of such event. [***] shall be the lead party in any such interference, ***Confidential Treatment Requested opposition, or reexamination relating to the Prior Joint Patents or Collaboration Product Patents, subject to the provisions of this Section 7.2.4(c7.2(c)(iii). [***] shall have the right to review and consult with [***] regarding any submission to be made in connection with such proceeding. Notwithstanding the foregoing or any other provision of this Agreement to the contrary:
Appears in 1 contract
Samples: License and Collaboration Agreement (Metabasis Therapeutics Inc)